Skip to content

Effects of Cardiac Resynchronization Therapy on the Microcirculation (CaRe-Mi)

Effects of Cardiac Resynchronization Therapy on the Microcirculation (CaRe-Mi) - Microcirculation during cardiac resynchronization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32204
Enrollment
51
Registered
2008-08-18
Start date
2008-06-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alterations of microcirculation chronic heart failure weak heart

Interventions

5 different areas of the sub-lingual microcirculation will be imaged by use of Sidestream Dark Field (SDF) imaging hand microscope. Images will be acquired during: no pacing (if the patient is not p

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Older than 18 years * Chronic heart failure * CRT device implanted * Informed consent is given

Exclusion criteria

Exclusion criteria: * Younger than 18 years * Pacing dependency (no intrinsic rhythm) * Pre-existing renal failure requiring dialysis * Known haemoglobin diseases, such as sickle cell anemia or thallasemia * Known allergy to acetylcholine or its additives * Missing informed consent * Inability to walk

Design outcomes

Primary

MeasureTime frame
The main study parameter is the CRT- and acetylcholine-related effects on the microcirculation as expressed as the change in mean functional capillary density during different pacing settings and pharmacologic vasodilatation.

Secondary

MeasureTime frame
Secondary parameters are additional microvascular parameters: red blood cell velocity and microvascular flow index (MFI). Furthermore, the correlation of microcirculatory and systemic hemodynamic parameters will be investigated.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)